William Blair
http://www.williamblair.comWilliam Blair & Company, L.L.C. is a Chicago-based investment firm offering investment banking, asset management, equity research, institutional and private brokerage, and private capital to individual, institutional, and issuing clients. Since 1935, it has been committed to helping clients achieve their financial objectives.
View Older Stories View More Recent Stories
-
Lyra Therapeutics (LYRA) Reiterated at Outperform by William Blair, Company Poised to Become a Major Player, Significant Disconnect in Valuation Exists, Remains Favorite Small-Cap Name,
-
Sachem Capital Corp. Announces Closing of Public Offering of $50.0 Million of 6.00% Notes
-
Banks in talks with distressed buyers on Russian assets - sources
-
William Blair Reiterates Revance Therapeutic (RVNC) at Outperform, Sees DAXI as a Blockbuster in the Making, Believes Approval is an Eventuality
-
UPDATE: William Blair Starts Brickell Biotech Inc. (BBI) at Outperform
-
Currencies Direct Announces £140 Million Strategic Investment from Blackstone
-
AmeriVet Veterinary Partners Acquired by AEA Investors LP and ADIA From Imperial Capital
-
UPDATE: William Blair Starts BRC Inc. (BRCC) at Outperform
-
Similarweb Ltd (SMWB) Management Meetings Convey Bullish Tone on Growth - William Blair
-
Form 497J WILLIAM BLAIR FUNDS
-
Stuck but not sweating it: some U.S. investors in Russia not kneejerk-selling
-
Sachem Capital Corp. Prices Registered Public Offering of $50.0 Million of 6.00% Notes
-
Sachem Capital Corp. Announces Registered Public Offering of Notes
-
ForgeRock to Present at Upcoming Investor Conferences
-
Allscripts (MDRX) to Sell the Net Assets of Its Hospitals & Large Physician Practices Business Segment to Constellation Software
-
Allscripts to Sell the Net Assets of Its Hospitals & Large Physician Practices Business Segment to Constellation Software
-
Analysis-Ukraine war raises spectre of Russia's first external debt default
-
Lightspeed Systems Receives Strategic Growth Investment from Genstar Capital
-
William Blair Reiterates Market Perform Rating on Allakos (ALLK), Believes lirentelimab May Ultimately Be Approved but Warns of Protracted Timelines and Additional Costs
-
William Blair Reiterates Albireo Pharma (ALBO) at Outperform, Bylvay Can Become a Blockbuster in Several Indications
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Dec 31
-
GTCR Invests in Industry Leader Experity to Drive the Future of On-Demand Care
-
GTCR Announces Acquisition of Experity
-
UPDATE: William Blair Downgrades On24 Inc. (ONTF) to Market Perform
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Dec 31
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Dec 31
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Dec 31
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Dec 31
-
Form 497J WILLIAM BLAIR FUNDS
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Dec 31
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Dec 31
-
Form 497J WILLIAM BLAIR FUNDS
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Dec 31
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Dec 31
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Dec 31
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Dec 31
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Dec 31
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Dec 31
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Dec 31
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Dec 31
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Dec 31
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Dec 31
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Dec 31
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Dec 31
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Dec 31
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Dec 31
-
Form 497 WILLIAM BLAIR FUNDS
-
Form 497K WILLIAM BLAIR FUNDS
-
Form 485BPOS WILLIAM BLAIR FUNDS
-
Form N-CSR WILLIAM BLAIR FUNDS For: Dec 31

